Private Equity
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Video: Landscaping Company BrightView Shares Slip in IPO Debut
Commercial landscaping provider BrightView shares moved slightly lower on Thursday following its debut as a public company on the New York Stock Exchange.
Will Tesla CEO Elon Musk Really Pulverize the Haters?
Elon Musk has drawn a line in the sand of short-sellers. Is GameStop really going to go private? Why hasn't the marked taken a nosedive yet?
Video: PlayAGS Shares Gain Steam Following NYSE IPO
Shares of casino slot machine maker PlayAGS, backed by Apollo Global Management, surged 14% in its NYSE debut on Friday.
Micro Caps Take the Spotlight at LD Micro Conference - Here's What to Expect
TheStreet is in Los Angeles all week, delivering you all the must-know information from one of the most important events all year for small cap investors.
Want to Make a Difference on Giving Tuesday? Consider These Charities
Take the hassle out of donating and go with a trustworthy option from Charity Navigator.
Which Brands Are Using Stevia Instead of Sugar?
Coke is expanding their portfolio with a purely Stevia sweetened drink next year.
Video: P&G Shareholders Will Likely Benefit From Peltz Battle
With news that Trian's Nelson Peltz has won more votes in his quest to secure a seat on Procter & Gamble's PG board, regardless of the final outcome, shareholders should benefit.
Billionaire David Rubenstein on What Rising Rates Means for Private Equity Deals
Billionaire private equity guru David Rubenstein, co-CEO and co-founder of The Carlyle Group doesn't expect rising interest rates to negatively impact his private equity deals.
Shark Tank's Kevin O'Leary Is More Bullish on the Russell 2000 Than the S&P 500
Kevin O'Leary's market outlook.